Resin Salve Versus Honey Treatment in Wound Care
Comparison of Resin Salve and Medical Honey in Wound Care in Vascular Surgery Patients - A Prospective, Randomized and Controlled Clinical Trial
1 other identifier
interventional
40
1 country
2
Brief Summary
In recent years, salve prepared from Norway spruce (Picea abies) resin and refined honey from manuka myrtle (Leptospermum scoparium), has successfully been used in medical context to treat both acute and chronic surgical wounds. The objective of this prospective, randomized and controlled clinical trial is to investigate healing rate and healing time of surgical wounds in patients, who have undergone peripheral vascular surgery, and whose complicated wounds are candidate for topical treatment with the resin or honey. In addition, factors contributing with delayed wound healing, antimicrobial properties, safety and cost-effectiveness of the resin salve and medical honey will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2013
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 8, 2013
CompletedFirst Posted
Study publicly available on registry
June 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedJanuary 18, 2016
January 1, 2016
2.7 years
May 8, 2013
January 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound Healing
Healing rate of acute or chronic surgical wound within 6 months after vascular surgery (%).
6 months
Secondary Outcomes (1)
Contributors for Wound Healing
6 months
Other Outcomes (1)
Other Pre-specified Outcome Measure
6 months
Study Arms (2)
Resin & honey
EXPERIMENTALAbilar 10% resin salve
Resin vs. honey
ACTIVE COMPARATORActivon Tube 25 g
Interventions
The resin salve may be spread directly onto the wound, after which the area is covered with a bandage suitable for local wound care. The bandage prohibits salve from moving away from the wound area. If the skin condition is more widespread or contains cavities or fistulae, the salve may be spread as a film with a thickness of at least 1 mm onto a gauze or gauze ribbon that is then used to fill the cavity or fistulae channel. Bandages are changed every 1-3 days, depending on the degree of infection and amount of wound secretion.
Wound care with the medical honey is carried out in the same manner than the resin salve treatment: honey may be spread directly onto the wound and the wound area is covered with a bandage suitable for local wound care. Similarly, if the skin condition is more widespread or wound contains cavities or fistulae, the medical honey may be spread as a film with a thickness of at least 1 mm onto a gauze or gauze ribbon that is then used to fill the cavity or fistulae channel. Bandages are changed every 1-3 days, depending on the severity of infection and amount of wound secretion.
Eligibility Criteria
You may qualify if:
- Infected of non-infected acute or chronic wound after vascular surgery.
- Need for topical wound care.
- Need for wound healing follow-up at the surgical outpatient department.
You may not qualify if:
- Life expectancy less than 6 months.
- Advanced malignant disease.
- Need for extensive surgical wound revision or skin transplantation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kuopio University Hospital
Kuopio, Kuopio, 70200, Finland
Kuopio University Hospital
Kuopio, Kuopio, FI-70029, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tommi Auvinen, MD
Kuopio University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2013
First Posted
June 4, 2013
Study Start
May 1, 2013
Primary Completion
January 1, 2016
Study Completion
January 1, 2016
Last Updated
January 18, 2016
Record last verified: 2016-01